In this Presentation learn about how Olaparib, a PARP inhibitor, is changing the way ovarian and breast cancers are treated. This presentation explains the disease background, treatment methods, and how patients in the Philippines can access genuine generic Olaparib tablets through LetsMeds.
Learn ...
In this Presentation learn about how Olaparib, a PARP inhibitor, is changing the way ovarian and breast cancers are treated. This presentation explains the disease background, treatment methods, and how patients in the Philippines can access genuine generic Olaparib tablets through LetsMeds.
Learn more about olaparib: https://www.letsmeds.com/olaparib-tablet-price-manila-philippines
Size: 3.69 MB
Language: en
Added: Oct 27, 2025
Slides: 13 pages
Slide Content
OLAPARIB: TARGETED
CANCER TREATMENT
IN THE PHILIPPINES
Addressing the Growing Need for Effective Therapy in
BRCA-Mutated Cancers
Table of Contents
Cancer Challenges in the Philippines
Ovarian Cancer and BRCA Mutations
BRCA-Positive Breast Cancer
Prostate & Pancreatic Cancer Applications
Introduction to Olaparib
Mechanism of Action
Cancer in the Philippines
Rising Cases
- Significant increase in ovarian, breast, prostate, and pancreatic cancers
- Limited early detection resources, especially in rural areas
- High mortality rates due to late-stage diagnosis
Treatment Needs
- Growing demand for targeted therapies with fewer side effects
- Need for more affordable treatment options
- Importance of maintenance therapy for long-term cancer management
Ovarian Cancer and BRCA
Ovarian cancer represents a significant health challenge in the Philippines, with many cases going
undetected until they reach advanced stages. This creates an urgent need for effective treatment options.
01 Late Detection 02 Genetic Risk 03 Targeted Therapy
PCE ar eS - BRCA1/2 mutations = PARP inhibitors essential
css - 5x higher cancer risk - Prevents cancer spread
stages . - Hereditary pattern - Reduces recurrence risk
RUE cools - Affects 4-7% of cases - Maintenance approach
= Fetal SISTEM: - Requires genetic testing - Improves survival rates
early intervention
- High recurrence rates
- Challenging to treat
- Guides treatment choice - Personalized medicine
BRCA-Positive Breast Cancer
01 Genetic Factors
- Linked to inherited BRCAI and BRCA2 gene mutations
- Significantly higher lifetime risk of developing breast cancer
- Often develops at younger ages than non-hereditary breast cancer
- PARP inhibitors like Olaparib provide targeted treatment
- Particularly effective as maintenance therapy after initial response
Beyond Gynecologic Cancers
Olaparib has shown promising results beyond its initial applications, demonstrating effectiveness in
treating both metastatic prostate cancer and pancreatic cancer with specific genetic mutations.
Prostate Cancer 02 Pancreatic Cancer 03 Clinical Benefits
- Effective for metastatic cases - Effective in BRCA-mutated - Improves overall survival
= Targets specific mutations cases - Delays disease progression
= Alternative when standard - Helps with advanced - Reduces tumor burden
treatments fail disease - Fewer side effects than
- Extends progression-free - Option after chemotherapy
survival chemotherapy = Oral administration
= Maintains quality of life - Targets DNA repair defects convenience
- Emerging treatment option - Slows disease progression - Maintenance therapy option
- Extends survival time
Introduction to Olaparib
Olaparip
What is Olaparib?
- A targeted cancer medicine
- Belongs to 'PARP inhibitor class
- Designed specifically for cancers with genetic
mutations
Otaparid
DNA pacspart
How Does It Help?
- Blocks cancer cells’ ability to repair damaged DNA
- Leads to cancer cell death
= Minimizes harm to healthy cells
Mechanism of Action
iS
SI
ÉS it
Targeting DNA Repair Block Treatment Benefits
- Specifically targets cancer - Prevents DNA repair - Stops/delays
cells with 'BRCA mutations’ = Creates synthetic lethality in cancer progression
cells = Works as ‘maintenance therapy’
Cost & Availability
Branded Options Generic Alternatives
- Original Olaparib 150mg tablets available in major cities -Ibyra Olaparib 150mg’ offers same active ingredient
- Found in pharmacies across Manila, Makati, and Cebu City - Equal effectiveness and safety profile
~ Higher price point can be challenging for long-term - Significantly more affordable for Filipino patients
= Limited availability in smaller Philippine cities = Accessible from anywhere in the Philippines
- Higher prices due to import markups and overhead cost - Lower prices through direct sourcing channels
- Requires in-person visits for prescription and purchase - Convenient home delivery eliminates travel needs
= Stock shortages common for specialized medications =Reliable stock of specialized cancer medications
- Mostly branded options with premium pricing = Includes affordable generic alternatives
- Immediate pickup but limited selection - Supports ongoing cancer treatment regimens
LetsMeds Online Options
Genuine Products
- Original Olaparib
- Ibyra Olaparib
- Quality assured
Nationwide Access
- Available across
all Philippine regions
Affordable Pricing Easy Ordering
- Competitive rates - Simple online process
- Lower than local - Fast delivery
pharmacies - Responsive support
Why Choose LetsMeds
Olaparib helps patients with ovarian, breast, prostate, and pancreatic cancers live longer and better.
With LetsMeds, Filipinos can now access these essential treatments safely, affordably, and conveniently.
Trusted Source Cost Effectiveness Convenience
- Specialized in oncology = Competitive pricing - Fast shipping
Inediciñes - significant savings vs local - Doorstep delivery
options